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Abstract
Background: The cattle tick, Rhipicephalus (Boophilus) microplus, affects livestock production in many regions of the
world. Up to now, the widespread use of chemical acaricides has led to the selection of acaricide-resistant ticks and to
environmental contamination. Gavac
plus is a subunit vaccine based on the recombinant Bm86 tick antigen expressed in
yeast, capable to control infestations of R. microplus under controlled and production conditions. The vaccine
constitutes the core element of broad control programs against this ectoparasite, in which acquired immunity in cattle
to Bm86 is combined with a rational use of acaricides. At present, the conventional vaccine scheme consists of three
doses that should be administered at weeks 0, 4 and 7, followed by a booster every six months.
Results: In this study we assayed a reduction in the number of the initial doses of Gavac
plus, evaluated the time
course and the level of bovine anti-Bm86 antibodies elicited, and analyzed the vaccine effect on ticks engorging
on immunized cattle under production conditions. Following three different immunization schemes, the bovines
developed a strong and specific immune response characterized by elevated anti-Bm86 IgG titers. A reduction in
the weight of engorging female ticks, in the weight of the eggs laid and also in R. microplus viable eggs
percentage was obtained by using only two doses of Gavac
plus administered at weeks 0 and 4, followed by a
booster six months later. This reduction did not differ from the results obtained on ticks engorging on cattle
immunized at weeks 0, 4 and 7. It was also demonstrated that anti-Bm86 antibody titers over 1:640, measured in
bovines immunized at weeks 0 and 4, were sufficient to affect weight and reproductive potential of female ticks as
compared with ticks engorging on unvaccinated animals. In addition, no statistically significant differences were
detected in the average weight of eggs laid by ticks engorged on immunized cattle that showed anti-Bm86
specific titers in the range of 1:640 to 1:81920.
Conclusion: The administration of two initial doses of Gavac
plus containing 100 μg of Bm86 antigen to non-
immunized cattle under production conditions is sufficient to affect the weight and the reproductive capacity of
R. microplus engorging females. According to these results, cattle herds’ manipulation and vaccine costs could be
potentially reduced with a positive impact on the implementation of integrated control programs against
R. microplus.
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Rhipicephalus microplus is an ectoparasite that currently
affects the cattle industry in many regions of the world and
it is also an important vector for the transmission of para-
s i t e si nd i s e a s e ss u c ha sa n a p l asmosis and babesiosis [1,2].
The use of acaricides is the most extended prophylac-
tic and therapeutic method to control ectoparasites.
However, some relevant drawbacks regarding their use
are the development of acaricide-resistant ticks after
repeated treatments, the chemical contamination of cat-
tle-derived products and of the environment [3-5]. In
the last years, these factors led to the selection of alter-
native strategies aiming to achieve a better control of
ectoparasites under safer approaches [6-8].
Efforts were primarily focused in the identification and
characterization of concealed Bm86-like antigens as vac-
cine candidates [9-13]. Other tick antigens such as
BmTI, serine protease inhibitors and 4D8 have been
described in recent years with marked potential for the
development of novel or combined vaccines [14-17].
However, only two Bm86-based vaccines commercially
available have been used in the field in different coun-
tries involving the immunization and monitoring of a
large number of bovines [18-21]. Nowadays, it is known
that using Bm86 for cattle immunization turns into a
highly effective control method if it is used as part of an
integrated control program in which acaricides are
simultaneously applied according to the infestation
index detected [21,22]. The most remarkable benefits
regarding the use of Bm86-derived vaccines are the
reduction in reproductive capacity of engorging females
and in the frequency of acaricide treatments.
The implementation of such programs using Gavac
plus
implies an immunization scheme that starts with the
administration of three doses at weeks 0, 4, and 7,
followed by boosters every six months [22-24]. This
method showed its effectiveness in the induction of high
antibody titers in bovines in spite of their race, sex, or
reproductive category [25]. However, this regimen
demands an arduous manipulation of cattle herds in the
first two months since treatment is performed. There-
fore, the implementation of a different schedule that
allows a reduction of manipulation and vaccine costs
constitutes a desirable fact for both practical and com-
mercial points of view. The Bm86 antigen contained in
Gavac
plus is obtained in a highly particulated form, with
high homogeneity and reproducibility in P. pastoris
yeast [26], under strict controls of a well-recognized bio-
technology industry [8,27]. Taking into consideration
that this antigen is immunogenically superior with
regard to the monomeric form of the protein [28], this
fact prompted us to investigate the capacity of two
doses of the vaccine to elicit immune responses and tick
damage similar to those achieved with the use of three
inoculations. In this work, we demonstrated that the
generation of specific antibodies and the physical
damage caused to female ticks engorging on cattle
immunized under production conditions remained
invariable after reducing in one dose the number of
initial administrations of the Gavac
plus vaccine.
Methods
Immunization experiments in cattle under production
conditions
Ten active production farms, located in the same geo-
graphical area (22°41’N, 82°53’W) in Candelaria munici-
pality, Pinar del Rio Province (on the Western part of
Cuba), were selected for the experiment. These farms
are located approximately 0.85 Km separated from each
other within an area of about 36 Km
2 and have equiva-
lent conditions of humidity, temperature, grass type and
indexes from moderate to high of natural infestations
with R. microplus. Farms were randomly assigned to
each experimental group, and different immunization
schemes with the Bm86-based Gavac
plus vaccine were
assayed. After immunizations took place, a sample of
30% of bovines per farm was selected at random to
measure the biological parameters of ticks under engor-
gement as it will be described below. In all cases, cross-
bred (Bos taurus × Bos indicus) non-immunized bovines,
with approximately the same age and composition, were
used. Manipulation of cattle herds during the immuniza-
tion trials was similar to all groups and was carried out
following the standard procedures for experimentation
with animals. The trials and the distribution of animals
by farms were done in the following way: Animals in
Farm 1 (86 animals), Farm 4 (102 animals) and Farm 7
(192 animals) were immunized at weeks 0, 4 and 7; ani-
mals in Farm 2 (106 animals), Farm 6 (161 animals) and
Farm 9 (150 animals) were immunized at weeks 0 and
4; animals in Farm 3 (116 animals), Farm 5 (151 ani-
mals) and Farm 8 (168 animals) were vaccinated at
weeks 0 and 7, while Farm 10 (131 animals) was consid-
ered as a control group with unvaccinated animals. Ani-
mals were immunized by using a deep intramuscular
injection, 21 × 11/2” needles and 2 mL of Gavac
plus,
containing 100 μg of recombinant Bm86 antigen emulsi-
fied in the oil-based adjuvant Montanide 888. Additional
booster doses were given to all vaccinated animals six
months after they were first immunized.
Serum collection and assessment of anti-Bm86 antibody
titers
Blood samples were taken from randomly selected
bovines at weeks 0, 4, 7, 12, 16, 20, 24 and 27, in order
to study the time course and anti-Bm86 specific
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were also considered for measuring the biological para-
meters of ticks under engorgement. Serum samples
were stored at -20°C until use. Anti-Bm86 IgG titers
were determined by ELISA as it was previously
described [29], with minor modifications. Titers from
individual animals were expressed as the maximum dilu-
tion having an OD492nm higher than two folds the aver-
age OD from a bovine seronegative control serum.
Determination of the average weight and reproductive
capacity of ticks engorging on vaccinated animals
As the experiment was conducted under production
conditions, adult female ticks engorging on vaccinated
c a t t l ew e r ec o l l e c t e df r o mar e p r e s e n t a t i v en u m b e ro f
animals at approximately each time point in which
serum samples were also taken (subsequently from
weeks 0 to 27). The effects produced by the three
schemes of immunization with Gavac
plus were evaluated
by measuring the following parameters: the average
weight of engorging females, the average weight of eggs
laid per gram of engorging female (referred as normal-
ized weight of eggs laid that expresses the reproductive
capacity of females considering that the eggs laid weight
is directly related to the weight of the engorging female),
and then the percentage of viable eggs.
For these objectives, adult engorging females were
washed with distilled water, dried, and individually
weighted. They were immobilized on adhesive tapes and
placed into acclimatized chambers at 28°C, 90% of
humidity and photoperiods of 12 hours, until oviposi-
tion. The number of eggs laid from every single tick was
then weighted and loaded in glass flasks with cotton
caps. They were kept in similar conditions of tempera-
ture and humidity until hatching. The percentage of
viable eggs (hatchability) was determined by direct
counting of larvae and eggs from each flask sample. The
comparison of hatchability between the two time points
selected (before starting the immunization trials and
after finishing them) was conducted for the three
schemes evaluated.
Statistical analysis
Specific anti-Bm86 antibody titers were determined
from a representative number of immunized animals at
each farm. Geometric mean titers (GMT) and standard
deviations were calculated for all the experimental
groups. Differences in anti-Bm86 GMT, in the weight of
engorging females, and in normalized weight of eggs
laid in each immunized group were determined from
weeks 0 to 27 using the non-parametric Friedman’st e s t .
These two last parameters measured on ticks when the
experiment ended were compared with values obtained
prior to immunization using a Mann-Whitney’st e s t ,
with p < 0.05. The medians of the percentages of viable
eggs from ticks engorging on bovines prior to immuni-
zation and after vaccination were compared for each
scheme by a Kruskal Wallis and a Dunn’st e s t .T h e
statistical software GraphPad Prism v4.0 was used in all
cases.
Results and Discussion
Different immunization regimens with Gavac
plus induce a
potent response of anti-Bm86 specific antibodies
Previous to the first immunization, serum samples from
cattle at each farm were assayed by ELISA for anti-
Bm86 antibodies and were found seronegative. Follow-
ing the three immunization schemes using the Bm86-
based Gavac
plus v a c c i n e( a tw e e k s0 ,4 ,7 ;0 ,4a n d0 ,7 ) ,
all the experimental animals developed a strong and
specific humoral immune response characterized by
high anti-Bm86 IgG titers. As it was proved by measure-
ments undertaken until week 27, specific antibody titers
were in all cases over 1:640, persisted in time and, as it
was expected, notably increased after revaccination at
week 24 (Figure 1). The immunogenicity found in these
schemes was in accordance with results reported during
controlled and field immunization trials using Bm-like
antigens, where elevated titers were promptly detected
[30,6,21,31,22]. At the present time, it has been demon-
strated that certain amounts of antibodies against Bm86
correlate with damage on ticks engorging on immunized
cattle [21,32]. Previous experiments also suggested that
1:640 constitutes an approximate titer cut-off where a
damaging effect mediated by specific antibodies can be
expected on ticks to some extent [21]. In cattle vacci-
nated with Bm86, titers decrease over time as the anti-
gen remains naturally hidden to the bovine immune
system during tick infestations occurrence. Therefore,
re-immunizations must be practiced for maintenance of
circulating antibodies. In this case, no statistically signif-
icant differences (p > 0.05) in the geometric mean of
titers were found when the animals immunized with dif-
ferent schemes were compared along the entire experi-
ment. As it can be seen in Figure 1, the reduction in
one dose of Gavac
plus did not affect the humoral
immune response generated. These antibody levels con-
trast with recent results obtained by other authors [33],
who reported low anti-Bm86 titers after three immuni-
zations with Gavac
plus in a trial to assess the efficacy of
Bm86 antigens from an African strain of B. microplus
and from B. annulatus (Israeli strain). Despite that fact,
these authors found the highest efficacy by using Gavac-
plus, thus confirming the existence of the epitopes
needed to induce damage against various tick species
and different B. microplus strains. The discrepancy they
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t e dt ot h ed i f f e r e n tp r o t e i n su s e df o rc o a t i n gt h ep l a t e s
in the ELISA for quantification of anti-Bm86 antibodies.
The level of the immune response obtained with two
initial vaccinations of Gavac
plus suggested that an effec-
tive action could be expected on ticks. Comparisons on
the regimens of vaccination and their effects on ticks
were conducted in this investigation under standard
production conditions. One farm remained with unvac-
cinated animals and was considered as a negative
control.
Two initial doses of Gavac
plus affected the reproductive
potential of ticks engorging on immunized cattle
The efficacy of this type of anti-tick vaccine, applied to
cattle under production conditions, has been mostly
assessed by measuring the reduction in the weight of
female ticks and the impact on their reproductive capa-
city [6,21,23,22]. Therefore, the effect of the three
immunization regimens with Gavac
plus was investigated
by measuring a possible reduction on the average tick
weight, on the average weight of the eggs laid by an
individual tick and on the total percentage of viable
eggs. These measurements were conducted in a sample
of bovines at each farm, from weeks 0 to 27. In the
immunized groups, the weight of engorging females was
significantly reduced after vaccination (Mann-Whitney’s
test, p < 0.05) compared with values at the beginning of
the experiment (Figure 2A). No significant variation was
detected in ticks detached from unvaccinated animals in
the evaluated period. The analysis of the normalized
weight of eggs laid also showed lower mean values at
t h ee n do ft h ea s s a yw i t ht h et h r e ei m p l e m e n t e d
schemes (Mann-Whitney’st e s t ,p <0 . 0 5 )( F i g u r e2 B ) .
Most importantly, no significant differences were found
in the weight of females engorging on immunized ani-
mals (Table 1) and in the normalized weight of eggs laid
(Table 2) when the three schemes were compared at
each time point using a Friedman’st e s t( p > 0.05). On
the other hand, ticks engorged on vaccinated cattle were
also visibly damaged (Figure 3), showing a characteristic
dark-red/yellow color previously described in immuniza-
tion experiments with Bm86-based vaccines [13]. As
previously stated, a reduction of the reproductive capa-
city of ticks engorged on immunized cattle tends to pro-
mote reduction of eggs and larvae in surrounding
ground, which in consequence diminishes the popula-
tion of ticks and delays the necessity for acaricide treat-
ments. The latter fact reduces as well the selective
pressure related to the generation of strains with
acquired resistance to chemicals. Despite the “knock-
down” effect is not a feature of this kind of vaccine, the
reduction in the frequency of application of acaricides is
one of the most valuable effects of vaccination that can
be expected at long-term [6,8].
In this experiment, the hatchability (percentage of
viable eggs) showed a moderate (although statistically
significant) reduction by the end of the experiment in
two of the three immunization schemes assayed with
respect to values observed before vaccination (Table 3).
Comparison through the non-parametric Kruskal-Wallis
and the Dunn’st e s t s( p < 0.05) indicated that immuniz-
ing at weeks 0 and 7 had no evident impact on the per-
centage of hatched eggs, which differed with the effect
Figure 1 Geometric mean of antibody titers against Bm86 determined by ELISA. At week 0 specific antibodies to Bm86 were not
detected. A Friedman’s test was employed at each time point for comparison of GMT. No statistical differences were found when the three
immunization schemes were compared. Standard deviation bars in the positive sense are indicated.
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Although the other analyzed parameters did not vary
within the three regimens proposed, this result sug-
gested a superior vaccine performance with the 0, 4, 7
and the 0, 4 schemes.
Anti-Bm86 antibody titers ranging from 1:640 to 1:81920
induced similar effects on the reproductive capacity of
ticks following immunization of cattle at weeks 0 and 4
To evaluate the relationship between the anti-Bm86
antibody titers and the effect of their variability in the
reproductive potential of engorging females after
immunization at weeks 0 and 4, the weight of eggs laid
was compared using ticks detached from bovines with
substantial differences in the levels of specific antibo-
dies to Bm86. We considered the widest possible
range, and bovines were divided into seven groups
according to titers that ranged from 1:640 to 1:81920.
Animals from the farm that were no vaccinated were
taken into account as an additional group for the ana-
lysis. The comparison showed that IgG titers over
1:640, reached after immunizations at weeks 0 and 4,
Figure 2 Average values of tick weight (A) and weight of eggs laid by an individual tick (B) measured at the beginning and at week
27 of the experiment. After vaccination, these variables showed a statistically significant reduction in the three schemes assayed (indicated
with an asterisk at week 27), according to a Mann-Whitney’s test with p < 0.05. Mean values measured from ticks engorged on unvaccinated
animals did not show a significant variation. Standard deviation bars in the positive sense are indicated.
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female ticks. The mean weight value of eggs laid by
ticks engorged in the groups of animals with titers in
the range of 1:640 to 1:81920, statistically differed
(p < 0.05) from those values measured on ticks
engorged on unvaccinated animals. Interestingly, we
found no significant differences in this parameter once
the immunized cattle was able to exhibit specific titers
against Bm86 over 1:640 (Figure 4). Taken together,
these findings imply that two initial doses of Gavac
plus
at weeks 0 and 4 can induce a significant degree of
tick damage suitable for the field implementation of
the proposed scheme. In recent experiments, it was
also demonstrated that two doses of a Bm86-based
vaccine were able to affect the reproductive potential
of the dog tick R. sanguineus due to the possible pre-
sence of cross-reactive protective epitopes in this anti-
gen [34]. The experiment here presented provides an
additional evidence for the necessity of revaccination
of cattle herds if titers decline below 1:640, which
tends to occur in about six months.
At present, the Gavac
plus vaccine is commercialized in
various countries in which it is applied as part of tick
control programs that combine the use of acaricide
treatments with acquired immunity to Bm86. Its practi-
cal value is also preceded by more than fifteen years of
research and application in the field. Although further
experiments could be added to the results that are here
presented, the application of the suggested scheme in
the field is currently in progress.
Conclusion
It has been demonstrated that two doses of Gavac
plus
administered at weeks 0 and 4 to non-immunized cattle
under production conditions are sufficient to elicit high
anti-Bm86 specific antibodies, which are able to mediate
damaging effects on ticks similar to those recorded with
the use of three doses. The reduction in the number of
inoculations could be a favorable issue when dealing
with a large number of bovines as the stress associated
Table 1 Average weight of engorging female ticks
detached from immunized cattle
Average weight (in mg) of engorging females
[95% confidence interval]
Week Immunizations at
0, 4, 7
Immunizations at
0, 4
Immunizations at
0, 7
0 202 [183-220]
a 215 [197-229]
a 189 [167-201]
a
4 178 [127-224]
a 186 [125 -285]
a 146 [121-152]
a
7 169 [141-192]
a 170 [157-196]
a 150 [138-166]
a
10 161 [152-173]
a 175 [163-192]
a 179 [161-194]
a
16 174 [170-191]
a 176 [136-202]
a 187 [168-201]
a
20 171 [156-187]
a 181 [171-188]
a 175 [160-192]
a
27 129 [117-141]
a 145 [141-157]
a 138 [126-144]
a
Identical letters within the same row indicate that no statistically significant
differences were found when the three schemes were compared. A
Friedman’s test was employed.
Table 2 Mean values of normalized weight of eggs laid
from ticks engorged on vaccinated animals
Mean weight (in mg) of eggs laid by individual ticks
[confidence interval 95%]
Week Immunizations at
0, 4, 7
Immunizations at
0, 4
Immunizations at
0, 7
0
4
525 [385-613]
a
438 [375-498]
a
512 [477-585]
a
388 [275-683]
a
548 [512-604]
a
426 [345-501]
a
7 456 [413-503]
a 493 [432-556]
a 475 [415-542]
a
10 421 [385-443]
a 435 [384-485]
a 463 [448-509]
a
16 480 [464-509]
a 489 [371-576]
a 498 [472-523]
a
20 448 [401-470]
a 442 [374-459]
a 449 [395-512]
a
27 425 [372-475]
a 415 [375-491]
a 440 [396-479]
a
Identical letters within the same row indicate that no statistically significant
differences were found when the three schemes were compared. A Friedman
test was used for comparison.
Figure 3 Ticks detached from cattle immunized at weeks 0 and
4 were visibly damaged showing a characteristic dark-red/
yellow color and a dehydrated appearance.
Table 3 Percentage of eggs that hatched determined
from ticks engorged on vaccinated cattle before and
after immunizations
Medians of hatchability (%)
Immunization scheme 0, 4, 7 0, 4 0, 7
Before immunization 96.77 96.10 94.89
After immunization 83.16 83.14 90.71*
Reduction (%) 13.61 12.96 4.18*
*Indicates a statistically significant difference (p < 0.05) with respect to the
groups immunized following the 0, 4, 7 and the 0, 4 schemes.
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milk and meat production in cattle herds.
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